can i take tirzepatide while on antibiotics Injections for Medical Weight Loss in Webster TX Tirzepatide Dosage Chart & Dosing

Obesity SURMOUNT-1 Trial In adults with obesity (without diabetes): Tirzepatide (15 mg) : 20.9% average body weight reduction over 72 weeks Semaglutide (2.4 mg) (based on STEP trials): ~14.9% average reduction STEP 5 Long-Term Results Semaglutide also demonstrated durable effects: At 104 weeks, patients maintained ~15% weight loss on semaglutide 2.4 mg (STEP 5) SELECT Trial Cardiovascular Benefit Semaglutide significantly reduced major adverse cardiovascular events by 20% in people with obesity and pre-existing heart diseaseindicating benefit beyond weight loss

Individual tolerance varies significantly

Farkas and Povlishock, 2007)

Studies have shown that Semaglutide reduces appetite, improves self-control when eating, reduces food cravings, and improves glycemic control

This makes it a powerful tool for individuals struggling with high blood sugar and weight management

Boyce VS, Mendell LM